Rapid Generation of Murine Bispecific Antibodies Using FAST-Ig<sup>TM</sup> for Preclinical Screening of HER2/CD3 T-Cell Engagers
Bispecific antibodies (BsAbs) can bind to two different antigens, enabling therapeutic concepts that cannot be achieved with monoclonal antibodies. Immuno-competent mice are essential for validating drug discovery concepts, necessitating the development of surrogate mouse BsAbs. In this study, we ex...
Main Authors: | Hikaru Koga, Haruka Kuroi, Rena Hirano, Hiroyuki Hirayama, Yoshiaki Nabuchi, Taichi Kuramochi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/13/1/3 |
Similar Items
-
Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
by: Pan H, et al.
Published: (2018-05-01) -
Large scale controlled Fab exchange GMP process to prepare bispecific antibodies
by: Xia Yao, et al.
Published: (2024-01-01) -
Bispecific Antibodies for IFN-β Delivery to ErbB2<sup>+</sup> Tumors
by: Vladislav S. Rybchenko, et al.
Published: (2021-12-01) -
Bispecific antibodies: design, therapy, perspectives
by: Sedykh SE, et al.
Published: (2018-01-01) -
Efficient production of bispecific antibody by FAST-IgTM and its application to NXT007 for the treatment of hemophilia A
by: Hikaru Koga, et al.
Published: (2023-12-01)